Literature DB >> 6117063

Beta-adrenoreceptor blocking drugs and thyroid hormones in hyperthyroid subjects.

M K Jones, J Birtwell, D R Owens, G R Jones, M Lewis.   

Abstract

Serum thyroid hormone concentrations were measured before and during 10 days' treatment with atenolol (200 mg/day), acebutolol (400 mg/day), oxprenolol (160 mg/day) and propranolol (160 mg/day) in 24 hyperthyroid patients. During propranolol treatment serum triiodothyronine (T3) concentrations fell significantly (P less than 0.05) but there was no change in thyroid hormone concentrations in the other groups although all patients reported a symptomatic improvement.

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 6117063      PMCID： PMC2424981          DOI： 10.1136/pgmj.57.666.207

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


  8 in total

Review 1.  Beta-adrenergic receptor blocking drugs in hyperthyroidism.

Authors:  P Turner
Journal:  Drugs       Date:  1974       Impact factor: 9.546

2.  Pituitary and peripheral resistance to thyroid hormone.

Authors:  E I Tamagna; H E Carlson; J M Hershman; A W Reed
Journal:  Clin Endocrinol (Oxf)       Date:  1979-05       Impact factor: 3.478

3.  Reduction of plasma triiodothyronine (T3) induced by propranolol.

Authors:  G Lotti; G Delitala; L Devilla; S Alagna; A Masala
Journal:  Clin Endocrinol (Oxf)       Date:  1977-06       Impact factor: 3.478

4.  Comparative trial of propranolol and practolol in hyperthyroidism.

Authors:  J K Nelson; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

5.  Comparison of propranolol and practolol in the management of hyperthyroidism.

Authors:  L E Murchison; P D Bewsher; M I Chesters; W R Ferrier
Journal:  Br J Clin Pharmacol       Date:  1976-04       Impact factor: 4.335

6.  The effect of oxprenolol, acebutolol and propranolol on thyroid hormones in hyperthyroid subjects.

Authors:  M K Jones; R John; G R Jones
Journal:  Clin Endocrinol (Oxf)       Date:  1980-10       Impact factor: 3.478

7.  Comparison of propranolol and metoprolol in the management of hyperthyroidism.

Authors:  L E Murchison; J How; P D Bewsher
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

8.  Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A.

Authors:  B Basil; R Jordan; A H Loveless; D R Maxwell
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.